DENTSPLY SIRONA Inc

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in millions, except per share amounts)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2024	2023	2024	2023
Net sales	$951	$947	$2,888	$2,953
Cost of products sold	456	452	1,376	1,389
Gross profit	495	495	1,512	1,564
Selling, general, and administrative expenses	390	372	1,204	1,204
Research and development expenses	40	46	123	141
Goodwill and intangible asset impairments	504	307	510	307
Restructuring and other costs	23	6	45	70
Operating loss	(462)	(236)	(370)	(158)
Other income and expenses:
Interest expense, net	18	19	53	61
Other (income) expense, net	(2)	(5)	(10)	13
Loss before income taxes	(478)	(250)	(413)	(232)
Provision (benefit) for income taxes	17	16	69	(28)
Net loss	(495)	(266)	(482)	(204)
Less: Net loss attributable to noncontrolling interests	(1)	—	(2)	(5)
Net loss attributable to Dentsply Sirona	$(494)	$(266)	$(480)	$(199)
Loss per common share attributable to Dentsply Sirona:
Basic	$(2.46)	$(1.25)	$(2.35)	$(0.94)
Diluted	$(2.46)	$(1.25)	$(2.35)	$(0.94)
Weighted average common shares outstanding:
Basic	201.0	211.8	204.7	212.7
Diluted	201.0	211.8	204.7	212.7

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.